The Association of Rheumatology Professionals (ARP) has developed programming highlighting the perspectives of ...

Results from the phase 3 VOCAL study demonstrate that oral vadadustat dosed 3 times per week successfully maintains hemoglobin levels vs standard ESA therapy in adult hemodialysis patients.

Higher treatment satisfaction, better treatment retention, and fewer adverse events reported for those choosing their treatment.

A celebrity's recent multiple sclerosis misdiagnosis highlights the complexities of medical liability and the error in judgment defense.

Ursodeoxycholic acid recommended as first-line therapy and to prevent recurrence after liver transplant for PBC.

HealthDay News — A simple vaginal swab may one day help women with abnormal bleeding learn whether they have endometrial cancer without first going through a painful biopsy.

The sNDA is supported by findings from the phase 3 MANGROVE trial, which demonstrated a 43% reduction in the risk of disease progression or death compared with chemoimmunotherapy in stem cell ...

The designation is based on phase 2 data demonstrating dose-dependent increases in total sleep time among children and adolescents, including those with comorbid neurodevelopmental disorders.

Real-world data show mortality, kidney, and cardiovascular benefits even among those with frailty and multimorbidity.

The Food and Drug Administration (FDA) has accepted and granted Priority Review to the Biologics License Application (BLA) for ifezuntirgene inilparvovec ...

The oral selective ROCK2 inhibitor aims to restore frataxin protein expression and will be evaluated in a 12-week phase 2a dose-ranging trial.

Findings for children younger than 5 years from 204 countries show cases rose 40 percent from 2019 to 2023 following years of vaccination declines ...